Ginkgo Bioworks

Company Snapshot

Founded: 2008
Entity Type: Public
Employees: 834
Region: U.S.
Revenue: $227.0 Millions
Revenue Year: 2024
Headquarter: Massachusetts, U.S.
Key Geographics: North America
Corporate Address: 27 Drydock Avenue 8th Floor Boston, Massachusetts 02210 U.S. Tel. +1-877-422-5362 www.ginkgobioworks.com

Company Overview

Founded in 2008 as a spinout from the Massachusetts Institute of Technology, Ginkgo Bioworks designs and operates production systems using designed organisms. Ginkgo develops organisms that can produce a range of products, including flavors and fragrances, industrial enzymes, nutritional ingredients, cosmetics, sweeteners, and pharmaceuticals.

Ginkgo works with companies in end-product areas to design microorganisms and develop a production method for creating the product. Ginkgo derives revenues from royalties on product sales.

End-use customers with whom Ginkgo works include Ajinomoto (food and pharmaceuticals) and Robertet (flavor and fragrances).

Robertet’s objective in working with Ginkgo is to develop a less expensive and less time-consuming path to producing a rose scent. The current method of doing this is to squeeze oils from the rose flowers’ petals. Ginkgo will also work on apricot, coconut, and mango fragrances in alliance with Robertet. 

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Ginkgo Bioworks In Reports

Synthetic Biology: Global Markets

BCC Research Market Analyst says global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029.

Top Ten Suppliers of Synthetic Biology Technology

BCC Research Market Analyst says global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a CAGR of 10.8%.

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Company's Business Segments

  • Cell Engineering : This segment includes research and development services performed under collaboration and license agreements relating to the company's cell programming platform.
  • Biosecurity : This segment consists of end-to-end biomonitoring and bioinformatic support services primarily provided to public health authorities.

Applications/End User Industries

  • Biopharma
  • Biotechnology
  • Government
  • Nutrition & Wellness
  • Agriculture
  • Biosecurity
  • Industrial